Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ginkgo Bioworks Holdings Inc.

7.84
-0.0300-0.38%
Post-market: 7.930.0900+1.15%19:47 EDT
Volume:648.46K
Turnover:5.05M
Market Cap:454.98M
PE:-0.74
High:7.95
Open:7.92
Low:7.61
Close:7.87
Loading ...

Stock Track | Ginkgo Bioworks Soars 5.02% as Partner Lucid Diagnostics' Esophageal DNA Test Accepted for Publication

Stock Track
·
11 Dec 2024

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

PR Newswire
·
11 Dec 2024

Applied DNA Sciences Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
11 Dec 2024

Ferrari has Formula One in its DNA, CEO says after Cadillac supply deal

Reuters
·
11 Dec 2024

DNA and Chintai Partner to Launch DNA Deal Desk, A Fully On-Chain Investment Platform (10 Dec)

CoinMarketCap
·
11 Dec 2024

We Think Enerpac Tool Group (NYSE:EPAC) Might Have The DNA Of A Multi-Bagger

Simply Wall St.
·
09 Dec 2024

4basebio CEO Increases Stake in Synthetic DNA Firm

TIPRANKS
·
29 Nov 2024

Lucid Diagnostics submits clinical evidence for EsoGuard Esophagea DNA test

TIPRANKS
·
20 Nov 2024

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test

PR Newswire
·
20 Nov 2024

Applied DNA Sciences files to sell 41.64M shares of common stock for holders

TIPRANKS
·
19 Nov 2024

Ginkgo Bioworks price target lowered to $6 from $7 at BTIG

TIPRANKS
·
15 Nov 2024

Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
15 Nov 2024

Ginkgo Bioworks Holdings Inc reports results for the quarter - Earnings Summary

Reuters
·
13 Nov 2024

Ginkgo Bioworks surges 14% as it ups 2024 revenue forecast

seekingalpha
·
13 Nov 2024

Ginkgo Bioworks Holdings GAAP EPS of -$1.08 beats by $2.24, revenue of $89.05M beats by $44.06M

seekingalpha
·
13 Nov 2024

Ginkgo Bioworks Holdings Q3 EPS $(1.08) Beats $(2.71) Estimate, Sales $89.05M Beat $45.00M Estimate

Benzinga
·
13 Nov 2024

Ginkgo Bioworks Holdings Inc: Reduction in Force Is Estimated to Achieve Over $85 Mln in Annualized Savings by Mid-2025

THOMSON REUTERS
·
13 Nov 2024

Ginkgo Bioworks: Will Substantially Consolidate Overall Real Estate Footprint by Exiting Several Facilities in Cambridge, Ma and Europe by Yr End

THOMSON REUTERS
·
13 Nov 2024

Press Release: Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Dow Jones
·
13 Nov 2024

Ginkgo Bioworks Advances Collaboration with Merck

MT Newswires Live
·
12 Nov 2024